RadNet Earnings Call: Record Results, Bold AI Bet

Radnet ((RDNT)) has held its Q4 earnings call. Read on for the main highlights of the call.

RadNet’s latest earnings call struck an upbeat tone, with management emphasizing record quarterly revenue and adjusted EBITDA, rapid progress in Digital Health, and a transformative AI acquisition. Executives acknowledged cost pressures, integration risks, and a temporary uptick in leverage, but argued that the long-term growth and margin outlook remains firmly positive.

Record Revenue and EBITDA Milestones

RadNet reported Q4 2025 revenue of $547.7M, up 14.8% year over year, and adjusted EBITDA of $87.7M, up 16.9%, both the highest in the company’s history. Management highlighted that this performance reflects both higher imaging volumes and improved mix, reinforcing the scalability of the core imaging platform.

Digital Health Delivers Standout Growth

Digital Health was a key growth engine, with Q4 2025 revenue jumping 48.2% to $27.9M and adjusted EBITDA rising 8.9% to $4.9M. For the full year, Digital Health generated $92.7M of revenue and $15.5M of adjusted EBITDA, underscoring RadNet’s shift toward higher-margin software and AI-enabled services.

Advanced Imaging Volumes and Mix Improve

Advanced imaging continued to gain share, with aggregate advanced imaging procedural volume up 14.1% in Q4 and same-center advanced imaging up 9.6%. These higher-value procedures represented 28.6% of total volume, a 178-basis-point increase from the prior-year quarter, supporting revenue density and margin expansion.

Gleamer Acquisition Expands Global AI Platform

RadNet closed the acquisition of Paris-based AI firm Gleamer for up to €230M in cash, adding roughly 700 customer contracts and about 130 employees. Gleamer brings four FDA-cleared and six CE-marked solutions and is expected to contribute about $30M of ARR, significantly scaling RadNet’s Digital Health footprint.

Digital Health ARR Building Rapidly

Digital Health annual recurring revenue stood at $75.4M as of December 31, 2025, providing a solid base of subscription-like income. On a pro forma basis including Gleamer and other deals, management expects ARR to approach roughly $140M by the end of 2026, with Gleamer itself having grown ARR at over a 90% CAGR since 2022.

Imaging Network Expansion and Partnerships

The company continued to build out its imaging network, opening seven de novo centers in 2025 and adding 13 centers in Southwest Florida, six in Indiana, and one in Virginia in early 2026. Of RadNet’s 418 centers, 151, or 36.1%, now operate within health system partnerships, which management views as a key driver of future joint ventures and regional scale.

Balance Sheet Strength and Receivables Discipline

RadNet ended 2025 with approximately $767M to $776M in cash and full availability on a $282M revolver, supporting its acquisition strategy and growth plans. Net debt to adjusted EBITDA was a conservative 1.0 times at year-end, while days sales outstanding improved to a record low of 29.5 days, signaling strong collections and working-capital discipline.

Guidance Points to Growth and Margin Upside

Management’s 2026 outlook calls for Imaging Center revenue growth of 17%–19%, with EBITDA growth outpacing revenue and driving margin expansion, despite around $30M of embedded labor cost inflation. Digital Health revenue is expected to surge 45%–55%, ARR to approach $140M, free cash flow to rise 29%–41%, and at least four new FDA clearances to support the AI roadmap.

EPS Momentum Lags Operational Progress

Despite robust top-line and EBITDA growth, adjusted EPS for Q4 2025 came in essentially flat at $0.23 versus $0.24 a year earlier. Management signaled that heavy investment in growth, integration costs, and higher labor expenses are muting near-term EPS leverage, even as the underlying businesses strengthen.

Near-Term EBITDA Drag from AI Acquisitions

Executives cautioned that recent AI deals will weigh on profitability in the short term, including an expected Digital Health EBITDA drag of up to about $5M in 2026 from Gleamer. Earlier acquisitions such as iCAD and C-MODE have also been negative EBITDA contributors during integration, with synergy capture still in progress.

Labor Cost Inflation Pressures Margins

The 2026 guidance bakes in roughly $30M of same-center labor cost increases, implying about a 4% average wage step-up across the network. Management believes productivity gains and operating leverage can offset much of this pressure, but investors should expect labor to remain a structural headwind.

Weather and Seasonality Cloud Early 2026

Severe winter weather in the Mid-Atlantic and Northeast has already been factored in as a headwind for Q1 2026, potentially dampening visit counts and scan volumes. The company framed this as a timing issue rather than a demand problem, with volumes expected to normalize as conditions improve.

Execution and Integration Risks in Focus

The string of strategic deals, including Gleamer and iCAD, introduces integration and execution risks, particularly around regulatory timelines and synergy delivery. Management is targeting about $7M of run-rate synergies from Gleamer and aims to move these assets to positive adjusted EBITDA by mid-2027, but investors will be watching milestones closely.

Leverage and Upfront M&A Cash Outlays

Pro forma for recent transactions, RadNet expects net debt to adjusted EBITDA to rise to roughly 1.6–1.8 times, temporarily elevating leverage as deals are absorbed. Early 2026 cash outlays included about $65M for Southwest Florida centers, roughly $9M for Indiana sites, and substantial cash for Gleamer, which reduces interest income and raises near-term financing needs.

In sum, RadNet’s earnings call painted a picture of a company trading near-term EPS and margin simplicity for long-term scale in imaging and AI-based diagnostics. With record results, strong liquidity, and ambitious growth plans, management is betting that investors will look past integration noise and focus on the expanding recurring revenue base and improving strategic position.